-
-
C649018-10mgCD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.Form:SolidIC50& Target:CD73
-
C649018-1mgCD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.Form:SolidIC50& Target:CD73
-
C649018-25mgCD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.Form:SolidIC50& Target:CD73
-
C649018-50mgCD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.Form:SolidIC50& Target:CD73
-
C649018-5mgCD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.Form:SolidIC50& Target:CD73
-
C655670-1mlCD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.IC50& Target:CD73
-
C647604-100mgCD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor, with an IC 50 of 2.6 nM for human CD73 . CD73-IN-4 is potential for the research of cancer immunologyIn VitroCD73-IN-4 (compound 4a) exhibits excellent potency against
-
C647604-10mgCD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor, with an IC 50 of 2.6 nM for human CD73 . CD73-IN-4 is potential for the research of cancer immunologyIn VitroCD73-IN-4 (compound 4a) exhibits excellent potency against
-
C647604-25mgCD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor, with an IC 50 of 2.6 nM for human CD73 . CD73-IN-4 is potential for the research of cancer immunologyIn VitroCD73-IN-4 (compound 4a) exhibits excellent potency against
-
C647604-50mgCD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor, with an IC 50 of 2.6 nM for human CD73 . CD73-IN-4 is potential for the research of cancer immunologyIn VitroCD73-IN-4 (compound 4a) exhibits excellent potency against
-
C647604-5mgCD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor, with an IC 50 of 2.6 nM for human CD73 . CD73-IN-4 is potential for the research of cancer immunologyIn VitroCD73-IN-4 (compound 4a) exhibits excellent potency against